Thomas M Moriarty
CIK 1412221 · EVP, M&A and Corporate Affairs · last filed 2026-05-12
Thomas M Moriarty is an EVP, M&A and Corporate Affairs who has filed 74 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ACI, was dated May 12, 2026. Across all open-market trades the lifetime net is −$75.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $50.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$50.00M
4
74
-$75.24M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACI | EVP, M&A and Corporate Affairs | 106,154 | $15.41 | $1.64M | $0 | 24 | 2026-05-12 |
| CVS | EVP & General Counsel | 474,393 | $101.96 | $48.37M | -$66.46M | 30 | 2023-01-04 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | — | — | — | $0 | 1 | 2012-06-05 |
| MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | Gen'l Counsel & Secretary, SVP | 0 | — | — | -$8.78M | 19 | 2012-04-03 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-12 | ACI | Grant (A) | — | $0 | EDGAR |
| 2026-04-23 | ACI | Mixed | +44,691 | $1.42M | EDGAR |
| 2026-04-20 | ACI | Mixed | — | $0 | EDGAR |
| 2026-04-09 | ACI | Exer (M) | — | $0 | EDGAR |
| 2026-03-04 | ACI | Mixed | +59,768 | $1.07M | EDGAR |
| 2026-02-10 | ACI | Grant (A) | — | $0 | EDGAR |
| 2025-12-04 | ACI | Exer (M) | — | $0 | EDGAR |
| 2025-11-10 | ACI | Grant (A) | — | $0 | EDGAR |
| 2025-08-12 | ACI | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | ACI | Grant (A) | — | $0 | EDGAR |